Compare ALLR & FARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLR | FARM |
|---|---|---|
| Founded | 2004 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6M | 28.3M |
| IPO Year | 2021 | 1994 |
| Metric | ALLR | FARM |
|---|---|---|
| Price | $1.43 | $1.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $9.75 | $2.75 |
| AVG Volume (30 Days) | ★ 219.2K | 129.9K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $320,000.00 | ★ $342,281,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.35 |
| 52 Week Low | $0.77 | $1.21 |
| 52 Week High | $2.35 | $2.06 |
| Indicator | ALLR | FARM |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 52.14 |
| Support Level | $1.34 | $1.21 |
| Resistance Level | $1.80 | $1.58 |
| Average True Range (ATR) | 0.14 | 0.01 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 2.50 | 75.00 |
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.